Further investigation based on the biological attributes of super-enhancers identified MEIS1 as a novel oncogenic transcription factor that played a key pro-survival role in Ewing sarcoma, via activating the transcription of APCDD1 cooperatively with EWS-FLI1. This evidence concerns the gene MEIS1 and Ewing sarcoma.